These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1019278)

  • 1. [Preliminary results of imurek treatment of multiple sclerosis].
    Müller J; Kreiner R; Sauermann W
    Psychiatr Neurol Med Psychol (Leipz); 1976 Dec; 28(12):755-61. PubMed ID: 1019278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Further experiences with the Imurek treatment in multiple sclerosis].
    Müller J; Sauermann W; Kreiner R
    Psychiatr Neurol Med Psychol (Leipz); 1981 Sep; 33(9):527-31. PubMed ID: 7302005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term immunosuppression in multiple sclerosis: evaluation of treatments begun before 1972].
    Sabouraud O; Oger J; Darcel F; Madigand M; Merienne M
    Rev Neurol (Paris); 1984; 140(2):125-30. PubMed ID: 6710012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunosuppressive treatment of multiple sclerosis. 4. Results of treatment with azathioprine and antilymphocyte globulin (author's transl)].
    Frick E; Angstwurm H; Blomer R; Strauss G
    MMW Munch Med Wochenschr; 1977 Sep; 119(35):1111-4. PubMed ID: 408666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary reports on a therapeutical trial in multiple sclerosis.
    Floris V; Spadaro M; Tilia G
    Riv Neurol; 1987; 57(3):185-8. PubMed ID: 3313667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prolonged treatment of multiple sclerosis with average doses of azathioprine. An evaluation of 15 years' experience].
    Lhermitte F; Marteau R; Roullet E; de Saxcé H; Loridan M
    Rev Neurol (Paris); 1984; 140(10):553-8. PubMed ID: 6438761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of 213 cases of multiple sclerosis treated with azathioprine from 1967- to 1982].
    Aimard G; Confavreux C; Ventre JJ; Guillot M; Devic M
    Rev Neurol (Paris); 1983; 139(8-9):509-13. PubMed ID: 6648202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine versus azathioprine in the long-term treatment of multiple sclerosis--results of the German multicenter study.
    Kappos L; Patzold U; Dommasch D; Poser S; Haas J; Krauseneck P; Malin JP; Fierz W; Graffenried BU; Gugerli US
    Ann Neurol; 1988 Jan; 23(1):56-63. PubMed ID: 3278672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Side effects of azathioprine (Imurel). Apropos of 313 patients treated for multiple sclerosis. Review of the literature].
    Ventre JJ; Guillot M; Confavreux C; Evreux JC; Aimard G
    Therapie; 1985; 40(3):195-202. PubMed ID: 4012666
    [No Abstract]   [Full Text] [Related]  

  • 10. A preliminary evaluation of azathioprine (Imuran) in the treatment of multiple sclerosis.
    Tucker WG; Kapphahn KH
    Henry Ford Hosp Med J; 1969; 17(2):89-92. PubMed ID: 5783817
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of progressive and severe forms of multiple sclerosis using a combination of antilymphocyte serum, azathioprine and prednisone. Clinical and biological results. Comparison with a control group treated with azathioprine and prednisone only. 4-year follow-up].
    Lhermitte F; Marteau R; de Saxcé H
    Rev Neurol (Paris); 1987; 143(2):98-107. PubMed ID: 3299618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of multiple sclerosis with azathioprine (Imuran)].
    Ciesielski T; Burczyk-Popko I; Goralski H; Sypniewski J; Cendrowski W
    Pol Tyg Lek; 1974 Jan; 29(3):101-2. PubMed ID: 4594954
    [No Abstract]   [Full Text] [Related]  

  • 13. [Efficacy and tolerance of cyclosporin A in the treatment of multiple sclerosis].
    Schluep M; Steck AJ; Despland PA; Regli F; Ochsner F; Berrut E; Gauthier G
    Schweiz Rundsch Med Prax; 1991 Jun; 80(24):670-2. PubMed ID: 2068440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pulse-dose cyclophosphamide therapy for chronic progressive multiple sclerosis].
    Watanabe T; Yamamoto T; Saito T; Sugano M; Tsukamoto T
    Rinsho Shinkeigaku; 1993 Jan; 33(1):15-20. PubMed ID: 8334769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis: trial of a synthetic polypeptide.
    Bornstein MB; Miller AI; Teitelbaum D; Arnon R; Sela M
    Ann Neurol; 1982 Mar; 11(3):317-9. PubMed ID: 7092185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multiple sclerosis--current status of therapy].
    Reichel D; Kölmel HW
    Z Arztl Fortbild (Jena); 1995 May; 89(2):151-8. PubMed ID: 7610682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New proposals for the treatment of multiple sclerosis. Preliminary study].
    Floris V; Spadaro M
    Riv Neurol; 1985; 55(3):169-84. PubMed ID: 4035256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy with interferon beta-1b and azathioprine in secondary progressive multiple sclerosis. A two-year pilot study.
    Fernández O; Guerrero M; Mayorga C; Muñoz L; Leán A; Luque G; Hervás M; Fernández V; Capdevila A; de Ramón E
    J Neurol; 2002 Aug; 249(8):1058-62. PubMed ID: 12195454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interferon beta-1b now also for the secondary progressive form of multiple sclerosis?].
    de Haan RJ; Vermeulen M
    Ned Tijdschr Geneeskd; 1999 Apr; 143(14):709-11. PubMed ID: 10347623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azathioprine and methotrexate in multiple sclerosis.
    Fernández O; Fernández V; De Ramón E
    J Neurol Sci; 2004 Aug; 223(1):29-34. PubMed ID: 15261557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.